Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Non rejection bioreabsorbable scaffold for jaw implant, developed by Custom-Fit

10.02.2009
The EU funded project Custom-Fit has been working on a solution to the rejection issue of mandibular implants: a scaffold made using a brand new material which is bioreabsorbable, that is, once implanted, it is substituted by re-grown natural bone in 6-12 months.

The Custom-Fit project is a technological research program involving 30 partners from 12 European countries. Its goal is the development a new manufacturing paradigm for producing personalised products, customised to the individual shape of the human body.

This has been done by integrating Scanning Technologies, newly developed CAD systems (Computer Aided Design) and Rapid Manufacturing technologies, the so called ‘additive techniques, which build a object layer by layer, starting from a 3D design, adding material where needed instead of removing it where not.

The mandible implant has been chosen as one of the test benches to try out this new manufacturing technology, together with knee implants, trans-femoral prosthesis, and two consumer goods, motorbike seats and motorbike helmets, products that are well suited to be customised to meet individual body shapes.

The Custom-Fit way to manufacture a mandible implant takes advantage of the best available technologies in design, in material science and in manufacturing, thanks to the member partners of the Custom-Fit consortium.

The process is the following (Image #2). The jaw bone geometry is studied through Computerised Tomography, CT images are then worked using specialised software (Mimics by Materialise) capable of extracting the jaw bone surface in a standard file format for later surface design which uses STL (Standard Triangulation Language). This is capable of distinguishing the damaged part of the bone from the healthy one.

Then, a surface model of the implant, which has to replace the damaged bone part, is easily designed with a CAD system (3-matic, by Materialise in Belgium) that allows the direct playing with facet models (STL-files) avoiding the conversion to CAD-surfaces, which normally requires a long computer processing time; this dramatically shortens the implant design phase. Here, engineers and surgeons work in collaboration to decide were to cut the jaw and consequently the size of the scaffold.

The 3D model of the implant is then completed by adding the internal structure, i.e. adding porosity using more design software called Innerspace that was developed by the Custom-Fit partner, TNO, in the Netherlands.

Finally the model is sliced ready to be manufactured on a special Rapid Manufacturing tool, capable of printing multi-material and porous objects, using high viscosity resins, the Inkjet Printing tool also developed by TNO.

And one of the resins printable by IP is the bioreabsorbable resin developed by DSM, a Dutch company and Custom-Fit partner, that is responsible for new material development. First samples have been successfully printed (Image #3).

It will take years for the new scaffolds to be approved for implantation in human beings, but the approval procedure has now been started, with In-Vitro Cytoxicity tests.

Several advantages will be brought about by bioreabsorbable scaffolds: no rejection of the foreign material, new bone will be able to grow over time (for children), further treatment like dental implants will remain possible and definitively the implant will not be a foreign object any more, but will be completely replaced by new natural bone.

It is a revolution in implant surgery, Custom-Fit made the first step.

Sunny Martínez | alfa
Further information:
http://www.custom-fit.org

More articles from Health and Medicine:

nachricht Hepatitis: liver failure attributable to compromised blood supply
19.12.2018 | Technische Universität München

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New megalibrary approach proves useful for the rapid discovery of new materials

Northwestern discovery tool is thousands of times faster than conventional screening methods

Different eras of civilization are defined by the discovery of new materials, as new materials drive new capabilities. And yet, identifying the best material...

Im Focus: Data storage using individual molecules

Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.

Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

New megalibrary approach proves useful for the rapid discovery of new materials

19.12.2018 | Materials Sciences

Artificial intelligence meets materials science

19.12.2018 | Materials Sciences

Gut microbiome regulates the intestinal immune system, researchers find

19.12.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>